Global technology and IT services provider FPT has launched MediSight, an AI-powered framework designed to help healthcare organizations, medical device manufacturers, and pharmaceutical companies accelerate digital transformation and strengthen regulatory compliance.
Built on FPT’s FleziPT AI-first ecosystem and guided by its CASAN transformation framework, MediSight is structured around three core layers: a cloud-native Healthcare Insight Platform for interoperable data management, the MediSight Crew of autonomous AI agents and digital workers, and MediSight Verse, a portfolio of applications spanning clinical service management, claims administration, remote care, patient engagement, clinical trials, medical imaging, and healthcare analytics.
Mark Scrivens, CEO of FPT United Kingdom, said the framework targets the NHS’s shift from analogue to digital operations by connecting fragmented data and reducing administrative burden. The framework supports GDPR, HIPAA, HITRUST r2, and ISO 27001 compliance and is designed for deployment across major cloud environments.
“The next phase of healthcare innovation demands systems that don’t just store data, but actively reason through it,” said Chu Canh Chieu, FPT Software Vice President and Head of Healthcare and Life Sciences.
